Pay in 4 interest-free payments of $25.00 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
InChi: InChI=1S/C25H30N2O5/c1-15-21(24(29)32-18-7-5-4-6-8-18)22(16-9-11-17(12-10-16)27(30)31)23-19(26-15)13-25(2
Z1124160693
6 nM versus Kd ≥ 10
C6H6O3S/c1-4-24-20(29)12-18-22-27-26-13(2)28(22)19-10-9-16(30-3)11-17(19)21(25-18)14-5-7-15(23)8-6-14
InChi: InChI=1S/C23H22FN7O3/c1-14(30-5-4-20-18(23(30)32)9-17(11-25-20)34-7-6-33-3)21-27-28-22-19(24)8-15(13-31(21)22)16-10-26-29(2)12-16/h4-5
(S)-MRI-1867 Size:Contact [email protected] for quotation InChi: InChI=1S/C25H30N2O5/c1-15-21(24(29)32-18-7-5-4-6-8-18)22(16-9-11-17(12-10-16)27(30)31)23-19(26-15)13-25(2(S) MRI 1867 is a peripherally restricted, orally bioavailable dual cannabinoid CB1 receptor and inducible NOS (iNOS) antagonist. (S) MRI 1867 ameliorates obesity induced chronic kidney disease (CKD). Product information CAS Number: 1998760 00 1 Molecular Weight: 547. 98 Formula: C25H21ClF3N5O2S Chemical Name: (S) 3 (4 chlorophenyl) N' (1 iminoethyl) 4 phenyl N ((4 (trifluoromethyl)phenyl)sulfonyl) 4, 5 dihydro 1H pyrazole 1 carboximidamide Smiles:
US$ 129.00
US$ 19.00
US$ 225.00
US$ 85.00
US$ 99.00
US$ 89.00
US$ 99.00
US$ 43.95
US$ 80.00
US$ 104.00